Coty (COTY) Stock “Hold” Rating Maintained at RBC Capital; The PT Given is $22.0000, Tetraphase Pharmaceuticals (TTPH) Sentiment Is 1.29

July 17, 2017 - By Michael Collier

Tetraphase Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The company has market cap of $314.06 million. The Firm uses its chemistry technology to create antibiotics for multidrug-resistant infections. It currently has negative earnings. The Firm is developing its lead product candidate, eravacycline, a fully synthetic tetracycline derivative, as a spectrum intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of multidrug-resistant infections, including multidrug-resistant gram-negative infections.

Among 12 analysts covering Coty (NYSE:COTY), 4 have Buy rating, 1 Sell and 7 Hold. Therefore 33% are positive. Coty has $33 highest and $16 lowest target. $23.53’s average target is 28.02% above currents $18.38 stock price. Coty had 29 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Coty Inc (NYSE:COTY) has “Sell” rating given on Friday, August 14 by B. Riley & Co. Sterne Agee CRT initiated the shares of COTY in report on Tuesday, July 21 with “Neutral” rating. The firm has “Buy” rating by Stifel Nicolaus given on Monday, October 24. The rating was maintained by Citigroup with “Neutral” on Thursday, August 25. The stock of Coty Inc (NYSE:COTY) has “Buy” rating given on Monday, October 3 by Bank of America. On Monday, April 18 the stock rating was downgraded by Bank of America to “Neutral”. On Friday, September 9 the stock rating was initiated by Berenberg with “Sell”. The firm has “Neutral” rating by B. Riley & Co given on Thursday, September 29. The company was upgraded on Friday, November 18 by Berenberg. The stock has “Outperform” rating by BMO Capital Markets on Friday, December 16.

Coty Inc. is a beauty company. The Company operates through four divisions: Fragrances, Color Cosmetics, Skin & Body Care and Brazil Acquisition. The company has market cap of $13.83 billion. The Company’s fragrance products include a range of men’s and women’s products. It currently has negative earnings. The Company’s fragrance brands include Calvin Klein, Marc Jacobs, Davidoff, Chloe, Balenciaga, Beyonce, Bottega Veneta, Miu Miu and Roberto Cavalli.

Analysts await Coty Inc (NYSE:COTY) to report earnings on August, 15. They expect $0.10 EPS, down 23.08% or $0.03 from last year’s $0.13 per share. COTY’s profit will be $75.24 million for 45.95 P/E if the $0.10 EPS becomes a reality. After $0.15 actual EPS reported by Coty Inc for the previous quarter, Wall Street now forecasts -33.33% negative EPS growth.

Investors sentiment decreased to 2.21 in 2016 Q4. Its down 0.98, from 3.19 in 2016Q3. It turned negative, as 68 investors sold Coty Inc shares while 39 reduced holdings. 134 funds opened positions while 102 raised stakes. 473.22 million shares or 6.83% less from 507.90 million shares in 2016Q3 were reported. Cutter Brokerage Inc holds 0.17% or 22,975 shares. Loring Wolcott & Coolidge Fiduciary Llp Ma invested 0% in Coty Inc (NYSE:COTY). New Jersey-based Blackrock Investment Mngmt Llc has invested 0.02% in Coty Inc (NYSE:COTY). Parthenon Ltd Liability has invested 0.55% in Coty Inc (NYSE:COTY). Blackrock Institutional Tru Na holds 0.04% or 12.99M shares in its portfolio. The New York-based Hap Trading Ltd Company has invested 0.82% in Coty Inc (NYSE:COTY). Rocky Mountain Advisers Limited Com reported 0.01% in Coty Inc (NYSE:COTY). Dynamo Internacional Gestao De Recursos Ltda holds 16.83% or 6.87 million shares in its portfolio. Sweden-based Livforsakringsbolaget Skandia Omsesidigt has invested 0.03% in Coty Inc (NYSE:COTY). Cubist Systematic Strategies Ltd Liability Corporation owns 12,553 shares or 0.02% of their US portfolio. 25,000 were accumulated by Polar Asset Management Partners Incorporated. Tobam, France-based fund reported 1.58 million shares. Fjarde Ap holds 102,185 shares. Deutsche National Bank & Trust Ag holds 1.56 million shares or 0.02% of its portfolio. Bnp Paribas Arbitrage Sa reported 237,350 shares.

Since February 10, 2017, it had 12 insider buys, and 0 insider sales for $82.42 million activity. McMullen Greerson Greene had bought 14,350 shares worth $271,430 on Tuesday, May 23. On Friday, May 26 the insider HUBER EDGAR O. bought $1.52M. Froidefond Sebastien had bought 32,300 shares worth $597,550 on Friday, March 3. On Wednesday, February 15 the insider Pane Camillo bought $1.41M. $75.91 million worth of Coty Inc (NYSE:COTY) shares were bought by JAB Cosmetics B.V.. Another trade for 26,500 shares valued at $503,447 was bought by HARF PETER.

The stock increased 0.66% or $0.12 on July 14, reaching $18.38. About shares traded. Coty Inc (NYSE:COTY) has declined 25.39% since July 17, 2016 and is downtrending. It has underperformed by 42.09% the S&P500.

Analysts await Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) to report earnings on August, 3. They expect $-0.77 earnings per share, down 63.83% or $0.30 from last year’s $-0.47 per share. After $-0.79 actual earnings per share reported by Tetraphase Pharmaceuticals Inc for the previous quarter, Wall Street now forecasts -2.53% EPS growth.

Rhenman & Partners Asset Management Ab holds 0.23% of its portfolio in Tetraphase Pharmaceuticals Inc for 300,000 shares. Rock Springs Capital Management Lp owns 698,000 shares or 0.19% of their US portfolio. Moreover, Eventide Asset Management Llc has 0.16% invested in the company for 600,000 shares. The Michigan-based Dow Chemical Co De has invested 0.03% in the stock. Tekla Capital Management Llc, a Massachusetts-based fund reported 192,322 shares.

The stock increased 0.65% or $0.05 on July 14, reaching $7.8. About shares traded. Tetraphase Pharmaceuticals Inc (TTPH) has risen 106.58% since July 17, 2016 and is uptrending. It has outperformed by 89.88% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: